Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
- 1 January 2016
- book chapter
- Published by Elsevier
- Vol. 130, 95-190
- https://doi.org/10.1016/bs.ai.2015.12.002
Abstract
No abstract availableKeywords
This publication has 533 references indexed in Scilit:
- Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancerThe Journal of Pathology, 2013
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic ValuePLoS Medicine, 2013
- Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinomaOncoImmunology, 2013
- Infiltrating lymphocytes and human papillomavirus‐16–associated oropharyngeal cancerThe Laryngoscope, 2011
- The emerging role of nuclear factor kappa B in renal cell carcinomaThe International Journal of Biochemistry & Cell Biology, 2011
- Human Renal Cell Carcinoma Induces a Dendritic Cell Subset That Uses T-Cell Crosstalk for Tumor-Permissive Milieu AlterationsThe American Journal of Pathology, 2011
- Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunityCancer and Metastasis Reviews, 2010
- HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphataseCancer Immunology, Immunotherapy, 2010
- A systematic review of humoral immune responses against tumor antigensCancer Immunology, Immunotherapy, 2009
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993